Evidence map›Paper›PMID 28944105›Full record

ArticleCurrent pathobiology reports2017

Tumor immunology viewed from alternative animal models-the

Maureen Banach, Jacques Robert

Open access · greenAbstract read
In one paragraph

Article in Current pathobiology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cells · 2019
    Review
  8. Article
  9. Frontiers in physiology · 2019
    Article
  10. Frontiers in physiology · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maureen BanachDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, USA.
Jacques RobertDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, USA.
University of Rochester Medical Center · US

Funding

A Xenopus Laevis Research Resource for ImmunologyR24AI059830 · NIAID · UNIVERSITY OF ROCHESTER · PI JACQUES Robert · 2004 to 2026
$7.7M
The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
The role of The Xenopus Nonclassical MHC class I molecule XNC10 in Tumor ImmunityF31CA192664 · NCI · UNIVERSITY OF ROCHESTER · PI BANACH, MAUREEN LUDMILA · 2015 to 2018
$153k
NCI NIH HHS F31 CA192664NIAID NIH HHS R24 AI059830NIAID NIH HHS T32 AI007285
6 · The paper itself

Abstract

a purpose of reviewNonmammalian comparative animal models are important not only to gain fundamental evolutionary understanding of the complex interactions of tumors with the immune system, but also to better predict the applicability of novel immunotherapeutic approaches to humans. After reviewing recent advances in developing alternative models, we focus on the amphibian B RECENT

findingsExperiments using MHC-defined inbred and cloned animals, tumor cell lines, effective reagents, sequenced genomes, and adapted gene editing techniques in C SUMMARY: Comparative studies with the

Indexed as

amphibiansinnate T cellsMHC class I-liketumor immunityvertebrates

Identifiers

PMID28944105
PMCPMC5606161
OpenAlexW2581901128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.